News & Updates
Filter by Specialty:
‘Breathing’ pillow promises calm, peace of mind to anxious individuals
Snuggling with a pillow that mimics the sensation of rising and falling breath can offer anxiety relief, as shown in a study.
‘Breathing’ pillow promises calm, peace of mind to anxious individuals
15 Mar 2022
β3 agonist safe, effective for treatment of bladder dysfunction in children
ß3-adrenergic receptor agonists (ß3 agonists), such as mirabegron, demonstrate effectiveness and a satisfactory safety profile as adjunctive therapy in the management of paediatric neurogenic detrusor overactivity (NDO) or overactive bladder, results of a study have shown.
β3 agonist safe, effective for treatment of bladder dysfunction in children
15 Mar 2022
Transgender people less likely to undergo cancer screening
Despite being at increased risk for breast and cervical cancer, transgender people experience inequalities in the uptake of routine cancer screening, a study has found.
Transgender people less likely to undergo cancer screening
15 Mar 2022
Corticosteroids help prevent hearing loss, neurologic sequelae in paediatric bacterial meningitis
Children with bacterial meningitis appear to fare well with corticosteroids, which lead to a lower incidence of hearing loss and neurologic sequelae and faster resolution of fever, according to a meta-analysis.
Corticosteroids help prevent hearing loss, neurologic sequelae in paediatric bacterial meningitis
15 Mar 2022
Sofosbuvir easy on the kidneys
Use of sofosbuvir-based direct-acting antiviral regimens for treating hepatitis C virus (HCV) in clinical trial participants with chronic kidney disease (CKD) does not appear to worsen estimated glomerular filtration rate levels, according to a study. Furthermore, the drug does not appear to contribute to an increased risk of end-stage renal disease among HCV patients with CKD treated in clinical practice.
